Case 1

A 78 y/o female was diagnosed with serous uterine cancer in February 2012

She underwent complete hysterectomy in the same month following diagnosis.  In 1997 she had left breast cancer and underwent lumpectomy, 4 months of chemotherapy and 2 months of radiation therapy.  So this new cancer diagnosis was a shock to patient.  The prognosis of the uterine cancer was not good.  I started her on the full strict Gerson Therapy on March 6, 2012.  Her CA125 tumor marker before starting Gerson Therapy was 43 (reference range is 0-35 U/mL).  The inflammation marker CRP high sensitivity was 7.5 (reference range is 0.00-3.00 mg/dL).  She had a history of elevated uric acid and was around 8-9 (Reference range is 2.5-7.1 mg/dL).  On March 20, 2012 the CA125 rose to 75.  The CRP-HS reduced to 5.04.  The uric acid was 8.8.  On April 24, 2012 the CA125 reduced to 19.  That signified the cancer had disappeared.

As of October 8, 2013, it has been 1 year and 6 months since the cancer disappeared and the CA125 tumor marker has remained within reference range at 11.5.  She met with her surgical oncologist in June, 2013 who determined that the pelvic exam was normal and was pleased with her normal status with no sign of recurrence.  Interestingly her CRP-HS remained normal at 1.24 and the uric acid level was also normal at 5.8.  At the start of the Gerson Therapy her initial weight was 210 pounds.  She lost 83 pounds in 12 months weighing 127 pounds.  To date she is holding her weight at 135.5 pounds.

Case 2

An 18 y/o female with a diagnosis of rheumatoid arthritis in September 2012 had ongoing symptoms of progressive arthritis for 2 years prior to the diagnosis

She came to see me in February 2013 for the initial Gerson Therapy consultation.  She had terminated school 2 months prior due to deteriorating health condition.  She was unable to walk independently.  She required hand held assistance to get around.  She walked very slowly and only within room distances at a time.  Her left wrist and foot had very limited mobility and function.  She started on the strict Gerson Therapy in late February 2013.  Her baseline hemoglobin was 10.3 in early January 2013.  Serum iron prior to starting the therapy was 18 (reference range is 35-155 ug/dL).  The rheumatoid factor was 223 (reference range <=14 IU/mL).  The inflammation marker erythrocyte sedimentation rate (ESR) was 70 (reference range is 0-32 mm/hr).  1 month into the Gerson Therapy she already felt much better.  She was able to walk with minimal assistance from a family member.  She had a little more energy than when she started. But she still had difficulty waking up and required 10 hours sleep.  Her serum iron increased to 31 and the ESR reduced to 64.

4 months into the Gerson Therapy she was already going up and down the stairs at home (13 steps).  Interestingly she started having a regular monthly, which she has not had in a very long time.  The ESR reduced to 35.  In late October 2013 (over a year after the initial diagnosis) she is walking normally without any assistive device with the help of a few sessions of physical therapy rehabilitation upon my recommendation.  Her energy level is significantly increased.  She is sleeping well.  She gets up in the morning at 8 AM daily (used to be 11 AM).  Her ESR was 26, which is within normal limits.  The rheumatoid factor had reduced to 72.6 is expected to normalize by the summer of 2014.  But her activities of daily living are already normal.  Tentative plan is to be able to return to school in the spring of 2014.

Case 3

A 72 y/o male was diagnosed with Myasthenia Gravis in November 2012

The initial symptom of concern was a droopy left eyelid and intermittent double vision.  This autoimmune neuromuscular disease is characterized by fatigability.  Muscles become weaker with activity and improve with rest.  Conventional medical treatments typically consists of symptom-based medications (acetylcholinesterase inhibitors and/or immunosuppressants).  Instead of following the conventional medical treatment option, he chose the Gerson Therapy.  He was seen by me in April 2013.  He started with dietary changes but did not officially start the Gerson Therapy until the end of May 2013.  His baseline acetylcholine binding antibody blood test was 41.08 (reference range <=0.30) in January 2013.  His total cholesterol was 253 (reference range <200 mg/dL).  LDL (bad) cholesterol was 171 (reference range <100 mg/dL).  One month after starting the Gerson Therapy he lost 17 pounds.  His total cholesterol was 202.  LDL was 121.  The acetylcholine binding antibody test was 32.6.  He was still having experiencing energy.

Four months into the therapy he discontinued (on his own) the acetylcholinesterase inhibitor mestinon.  He felt his energy level was improving.  His neurologist was not pleased with patient discontinuing the medication but admitted that the patient was asymptomatic for myasthenia gravis.  The acetylcholine binding antibody test had reduced to 27.2.  The total cholesterol reduced to 227.  Five months into the therapy (November 2013) he remains asymptomatic for MG.  He swims for exercise.  He weighed in at 188.2 pounds (lost 36.6 pounds).  His ach binding antibody continues to decrease and was 19.9 in early November.  His latest test on November 27 showed 14.10.  So it continues to decrease.  His total cholesterol reduced to 176.  The LDL reduced to 103.  I am expecting his blood markers to normalize by spring or summer of 2014.  His energy level is expected to normalize also at that time.

Case 4

In early January 2013 a 65 y/o female came to me for physical therapy and chiropractic treatment to her left frozen shoulder of 2 months duration.

Her average pain level was 4/10 intensity but easily went up to 10/10 intensity at the slightest “wrong movement”.  Her left shoulder range of motion for forward flexion was 100 degrees (normal is 180 degrees) and internal rotation was 45 degrees (normal is 90 degrees).  Due to severe pain and guarding she avoided using the left arm.  She was painfully miserable.  She tried applying external heat and cold packs but no relief of pain.  She received joint mobilization/manipulation, stretching and light exercises under my care but after receiving 12 treatment sessions from January 14 to February 28, she did not show any significant improvement functionally and was still in severe pain.  She even tried anti-inflammatory enzyme supplements but to no avail.  Prior to her release from therapeutic rehabilitation I informed her about the benefits of the Gerson Therapy in addressing chronic pain and inflammation.  On April 8, 2013 she came for the initial Gerson Therapy consultation.  I started her on a modified Gerson protocol for non-malignant case.  Her initial lab test showed the CRP high sensitivity inflammation marker at 36.92 (reference range is 0.00-3.00 ng/mL).  Her total cholesterol was 235 (reference range is <200 mg/dL).  The LDL (bad) cholesterol was 167 (reference range is <100 mg/dL).  Her initial weight was 153 pounds at her height of 5 feet 4 inches.  7 weeks into the strict Gerson Therapy repeat lab testing showed the CRP high sensitivity significantly reduced to 6.5.  The cholesterol level did not improve but rose to 249.  The LDL cholesterol rose to 183.  However she reported significant pain relief with accompanied improvement in left shoulder mobility.  She also lost 12.5 pounds (weighing at 140.5 pounds).  She was encouraged to continue on the Gerson Therapy.

6 weeks later on July 9, 2013 she returned for her second follow up appointment.  Her weight was 136 pounds.  Her total cholesterol reduced to 223.  The LDL was down to 147.  Her CRP high sensitivity was 0.91.  So within 12 weeks of staring the Gerson Therapy her inflammatory marker CRP high sensitivity went from 36.92 down to 0.91, which is a remarkable improvement with accompanied resolution of pain.  She no longer favored her right arm in her activities of daily living.  Her left shoulder range of motion was almost full (about 90 percent of normal).  So I convinced her to receive 3 treatment sessions of physical therapy focusing mainly on stretching exercises.  Because of the normal inflammatory marker, I discontinued monitoring it.  On her third  follow-up appointment on August 22, 2013, her weight was down to 129 pounds.  The total cholesterol was 173.  And the LDL cholesterol was 100.  So within 6 months her left shoulder impairment was fully restored to normal and was asymptomatic.  Her cholesterol was essentially normal.  And she lost 25 pounds in the process, weighing 128 pounds.  This is the first time I have seen a severe frozen shoulder fully recovered from the Gerson Therapy.  I have been a physical therapist since 1990 and I have not seen this kind of remarkable recovery.

Case 5

In late July 2013 a 64 y/o female came to me with a history of undiagnosed multiple skin lesions, which she “diagnosed” as “skin cancer”.

She had been trying all sorts of natural remedies without seeking medical attention.  She even tried applying black salve to the lesions, which was painful, but did not resolve the recurring condition.  Finally she decided to try the Gerson Therapy.  Upon examination, she displayed several areas of skin damage by the frequent use of black salve and the ensuing inflammation that followed.  Her initial baseline lab showed abnormal liver function tests.  The alkaline phosphatase was 137 (reference range is 47-112 IU/L).  The AST was 225 (reference range is 0.40 IU/L.  The ALT was 498 (reference is 0-32 IU/L).  Ferritin was 409 (reference range is 15-150 ng/mL).  LDH was 225 (reference range is 0-214 IU/L).  Her vitamin D level was very low at 18.5 (reference range is 30-100 ng/mL).  I was mostly concerned about the condition of her liver.  The elevated ferritin and LDH gave me concern for possible malignancy.  I ordered an abdominal ultrasound to determine if there was structural evidence of a possible malignancy.  The ultrasound study was negative.  At any rate I stared her on the Gerson Therapy officially on August 1, 2013.

case5b

1 month into the Gerson Therapy repeat lab testing showed the following results:  Alkaline phosphatase 110 (normal).  AST 24 (normal).  ALT 22 (normal).  Ferritin 161 (still elevated but close to normal).  LDH 155 (normal).  This was a drastic but remarkable change within 4 weeks in the Gerson Therapy.  She felt significantly improved in her overall well-being and she could sense her health had improved greatly.  She also reported her skin felt smoother and plans to remain on the Gerson Therapy for a long time.  She has completed 4 months of the Gerson Therapy, and there has been no change in the lab tests, which are all within normal ranges.